Jens C Eickhoff

Clinical Trials and Observations

L. Staudt, A. Rosenwald, W. Chan, 2007 .

Responses to second-line tyrosine kinase inhibitors are durable: an intention-to-treat analysis in chronic myeloid leukemia patients.

L. Staudt, A. Rosenwald, T. Greiner, 2012, Blood.